Blackstone to acquire Flatiron Park for $600m.

Synopsis

Blackstone agreed to acquire Flatiron Park, a 22-building complex, for $600m. Flatiron Park devotes about 15% of its campus to life-science tenants, including biotech firms like KBI Biopharma and Enveda Biosciences. BioMed Realty said it believes that eventually half the campus could be filled with life-science businesses because of intense demand in Boulder for specialized lab and office space.

Principals

target

Flatiron Park

bidder

Blackstone Group

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (1)

jacob werner

Co-Head of Americas Acquisitions at BLACKSTONE GROUP INC

Investor

bidder

Deals

£ 24.13 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy